Publikationen in Zusammenarbeit mit Forschern von Universidad Europea de Madrid (32)

2022

  1. Can you change your mind? An ERP study of cognitive flexibility and new evidence integration

    Biological Psychology, Vol. 172

  2. “Shikonin inhibits microglia activation and reduces CFA-induced mechanical hyperalgesia in an animal model of pain”

    Biomedicine and Pharmacotherapy, Vol. 150

2021

  1. G Protein-Coupled Estrogen Receptor Immunoreactivity in the Rat Hypothalamus Is Widely Distributed in Neurons, Astrocytes, and Oligodendrocytes, Fluctuates during the Estrous Cycle, and Is Sexually Dimorphic

    Neuroendocrinology, Vol. 111, Núm. 7, pp. 660-677

2020

  1. G Protein-Coupled Estrogen Receptor Immunoreactivity Fluctuates During the Estrous Cycle and Show Sex Differences in the Amygdala and Dorsal Hippocampus

    Frontiers in Endocrinology, Vol. 11

  2. Mitochondrial base excision repair positively correlates with longevity in the liver and heart of mammals

    GeroScience, Vol. 42, Núm. 2, pp. 653-665

2016

  1. Disrupted circadian rhythm as a common player in developmental models of neuropsychiatric disorders

    Current Topics in Behavioral Neurosciences (Springer Verlag), pp. 155-181

  2. Impact of gestational risk factors on maternal cardiovascular system

    Annals of Translational Medicine, Vol. 4, Núm. 13

  3. Maternal cardiac adaptations to a physical exercise program during pregnancy

    Medicine and Science in Sports and Exercise, Vol. 48, Núm. 5, pp. 896-906

2015

  1. Neonatal Treatment with a Pegylated Leptin Antagonist Induces Sexually Dimorphic Effects on Neurones and Glial Cells, and on Markers of Synaptic Plasticity in the Developing Rat Hippocampal Formation

    Journal of Neuroendocrinology, Vol. 27, Núm. 8, pp. 658-669

  2. The maternal deprivation animal model revisited

    Neuroscience and Biobehavioral Reviews, Vol. 51, pp. 151-163

2006

  1. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats

    European Journal of Pharmacology, Vol. 536, Núm. 1-2, pp. 204-210

  2. Fisiología hepática

    Fisiología humana (McGraw-Hill Interamericana de España), pp. 750-759

2005

  1. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 288, Núm. 3 51-3

  2. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats

    Journal of Endocrinology, Vol. 185, Núm. 3, pp. 467-476

  3. Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release

    Regulatory Peptides, Vol. 124, Núm. 1-3, pp. 113-118

  4. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 289, Núm. 6

  5. Spatial and temporal patterns of growth and differentiation of cone oil droplets in the chick retina

    Journal of Neuroscience Research, Vol. 79, Núm. 3, pp. 401-411

2004

  1. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 286, Núm. 1 49-1

  2. Papel del óxido nítrico en la respuesta del IGF-I hepático a la inflamación

    Mapfre Medicina, Vol. 15, Núm. 1, pp. 20-27

2003

  1. Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats

    European Journal of Pharmacology, Vol. 481, Núm. 2-3, pp. 293-299